UKBA saves £50m by re-negotiating IABS contract with IBM
United Kingdom Borders Agency

The United Kingdom Borders Agency (UKBA) has re-negotiated a key biometrics contract with IBM for constructing the Immigration & Asylum Biometric System (IABS), in a move that reportedly will save £50 million for the agency.

The re-negotiated biometrics contract with IBM is estimated to cost £191 million over the coming seven years. The savings were attained by ditching a component of the project that would have stored on the UK nationals.

The National Identity Assurance Service (NIAS) system, which will provide a database of fingerprints as well as facial images, will help authorities in controlling the entry of non-EU national into the UK.

The system will also help authorities maintain law and order in the country as it will make it easier to identify people with criminal records, and those who have previously been deported or been refused a visa.

Speaking on the deal, immigration minister Damian Green said, the deal would "strengthen our ability to control the entry of foreign nationals into the UK and identify those who pose a risk to our country."

Authorities will make use of the system to accelerate the checking of biometric visas, biometric residence permits and registration cards for asylum seekers. The new data base will replace a system first commissioned in 2000.

Latest News

Nvidia to license graphics technology to other companies
AMD announces ‘Seattle’ microprocessor for server systems
First baby born using 'safer' IVF method
GM recalling 193,652 SUVs from model years 2006 and 2007
Microsoft Office will take time to become available on tablets
Ofsted-style ratings for hospitals
Google to reveal some details about its high-flying balloons
Strong competition between Microsoft and Sony is good for industry: EA
Alcohol-related disease patients deserve better care
U.S. Navy ditches ALL CAPS message format
Nokia to unveil 41MP camera-equipped Lumia EOS smartphone next month
From 2016, Britain to regulate e-cigarettes as medicine